Resultats de la cerca - Barbara Carnemolla
- Mostrar 1 - 19 resultats de 19
-
1
-
2
Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy per Lorenzo Mortara, Enrica Balza, Antonino Bruno, Alessandro Poggi, Paola Orecchia, Barbara Carnemolla
Publicat 2018Revisão -
3
-
4
Human tenascin: primary structure, pre-mRNA splicing patterns and localization of the epitopes recognized by two monoclonal antibodies per Annalisa Siri, Barbara Carnemolla, Marco Saginati, Alessandra Leprini, Giorgio Casari, Francisco E. Baralle, Luciano Zardi
Publicat 1991Artigo -
5
-
6
Differentiation between High- and Low-Grade Astrocytoma Using a Human Recombinant Antibody to the Extra Domain-B of Fibronectin per Patrizia Castellani, Laura Borsi, Barbara Carnemolla, Attila Bíró, Alessandra Dorcaratto, Giuseppe Viale, Dario Neri, Luciano Zardi
Publicat 2002Artigo -
7
-
8
-
9
Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix per Barbara Carnemolla, Laura Borsi, Enrica Balza, Patrizia Castellani, Raffaella Meazza, Alexander Berndt, Silvano Ferrini, Hartwig Kosmehl, Dario Neri, Luciano Zardi
Publicat 2002Artigo -
10
Both CD133<sup>+</sup> and CD133<sup>–</sup> medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK‐mediated cytotoxicity per Roberta Castriconi, Alessandra Dondero, Francesca Negri, Francesca Bellora, Paolo Nozza, Barbara Carnemolla, Alessandro Raso, Lorenzo Moretta, Alessandro Moretta, Cristina Bottino
Publicat 2007Artigo -
11
Targeted Delivery of Tumor Necrosis Factor-α to Tumor Vessels Induces a Therapeutic T Cell–Mediated Immune Response that Protects the Host Against Syngeneic Tumors of Different His... per Enrica Balza, Lorenzo Mortara, Francesca Sassi, Stefano Monteghirfo, Barbara Carnemolla, Patrizia Castellani, Dario Neri, Roberto S. Accolla, Luciano Zardi, Laura Borsi
Publicat 2006Artigo -
12
Identification of a Glioblastoma-Associated Tenascin-C Isoform by a High Affinity Recombinant Antibody per Barbara Carnemolla, Patrizia Castellani, Marco Ponassi, Laura Borsi, Stefania Urbini, Guido Nicolò, Alessandra Dorcaratto, Giuseppe Viale, Greg Winter, Dario Neri, Luciano Zardi
Publicat 1999Artigo -
13
Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells. per Laura Borsi, Barbara Carnemolla, Patrizia Castellani, C Rosellini, Domizia Vecchio, Giorgio Allemanni, Sidney E. Chang, Joyce Taylor‐Papadimitriou, Hema Pande, Luciano Zardi
Publicat 1987Artigo -
14
Selective targeting of tumoral vasculature: Comparison of different formats of an antibody (L19) to the ED‐B domain of fibronectin per Laura Borsi, Enrica Balza, Marco Bestagno, Patrizia Castellani, Barbara Carnemolla, Attila Bíró, Alessandra Leprini, Jorge Sepúlveda, Óscar R. Burrone, Dario Neri, Luciano Zardi
Publicat 2002Artigo -
15
Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis per Roberta Castriconi, Alessandra Dondero, Raffaella Augugliaro, Claudia Cantoni, Barbara Carnemolla, Angela Rita Sementa, Francesca Negri, Romana Conte, Maria Valeria Corrias, Lorenzo Moretta, Alessandro Moretta, Cristina Bottino
Publicat 2004Artigo -
16
Selective targeted delivery of TNFα to tumor blood vessels per Laura Borsi, Enrica Balza, Barbara Carnemolla, Francesca Sassi, Patrizia Castellani, Alexander Berndt, Hartwig Kosmehl, Attila Bíró, Annalisa Siri, Paola Orecchia, Jessica Grassi, Dario Neri, Luciano Zardi
Publicat 2003Artigo -
17
Identification of PVR (CD155) and Nectin-2 (CD112) as Cell Surface Ligands for the Human DNAM-1 (CD226) Activating Molecule per Cristina Bottino, Roberta Castriconi, Daniela Pende, Paola Rivera, Marina Nanni, Barbara Carnemolla, Claudia Cantoni, Jessica Grassi, Stefania Marcenaro, Nicolas Reymond, Massimo Vitale, Lorenzo Moretta, Marc Lopez, Alessandro Moretta
Publicat 2003Artigo -
18
Periostin is a novel therapeutic target that predicts and regulates glioma malignancy per Andrei M. Mikheev, Svetlana A. Mikheeva, Andrew D. Trister, Mari Tokita, Samuel Emerson, Carolina A. Parada, Donald E. Born, Barbara Carnemolla, Sam Frankel, Deok‐Ho Kim, Rob G. Oxford, Yoshito Kosai, Kathleen R. Tozer-Fink, Thomas C. Manning, John R. Silber, Robert Rostomily
Publicat 2014Artigo -
19
Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis per Payal Naik, Paul D. Bozyk, J. Kelley Bentley, Antonia P. Popova, Carolyn M. Birch, Carol A. Wilke, Christopher D. Fry, Eric S. White, Thomas H. Sisson, Nabihah Tayob, Barbara Carnemolla, Paola Orecchia, Kevin R. Flaherty, Marc B. Hershenson, Susan Murray, Fernando J. Martínez, Bethany B. Moore
Publicat 2012Artigo
Eines de cerca:
Matèries relacionades
Biology
Antibody
Biochemistry
Cancer research
Immunology
Cell biology
Gene
Extracellular matrix
Fibronectin
Genetics
Molecular biology
Monoclonal antibody
Chemistry
Medicine
Alternative splicing
Cell
Gene isoform
Angiogenesis
In vitro
Pathology
Recombinant DNA
Cell culture
Cytotoxicity
Epitope
Exon
Internal medicine
RNA
RNA splicing
Antigen
Cell adhesion